21世纪经济报道记者季媛媛 4500个岗位，约10%的全球员工规模，1700亿日元（约10.7亿美元）的战略重组成本——这是日本制药巨头武田制药近日交出的一份“瘦身”成绩单。 按照武田自己的说法，这不是撤退，而是转型。根据一项被称为“转型计划”的重组行动，此次裁员旨在集中企业职能、精简管理层级，并寄望于技术手段实现流程自动化。但值得一提的是，武田特别在声明中强调，重组后预计还将产生约2200个...
Source Link21世纪经济报道记者季媛媛 4500个岗位，约10%的全球员工规模，1700亿日元（约10.7亿美元）的战略重组成本——这是日本制药巨头武田制药近日交出的一份“瘦身”成绩单。 按照武田自己的说法，这不是撤退，而是转型。根据一项被称为“转型计划”的重组行动，此次裁员旨在集中企业职能、精简管理层级，并寄望于技术手段实现流程自动化。但值得一提的是，武田特别在声明中强调，重组后预计还将产生约2200个...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.